Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014 - Volume 21, Number 7—July 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 7—July 2015
CME ACTIVITY - Research
Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014
The clinical manifestations of infection with human parechoviruses (HPeVs), members of the familyPicornaviridiae, are often indistinguishable from those caused by human enterovirus infections. Over the past decade, outbreaks of human parechovirus genotype 3 (HPeV3) have been reported from the Northern Hemisphere and are particularly well documented in Japan (where the virus was discovered), Canada, the United Kingdom, Denmark, and the Netherlands (1–4). Of the 16 HPeV genotypes, HPeV3 is the most aggressive and causes a sepsis-like syndrome in neonates (5). HPeV infection seems to follow a seasonal pattern; incidence is higher in summer and autumn (2,3). It can be spread by the fecal–oral and respiratory routes (4).
On November 22, 2013, Health Protection New South Wales (NSW), Australia, was notified of a possible cluster of HPeV cases at The Children’s Hospital at Westmead in Sydney. At that time, 7 neonates had experienced rapid onset of acute sepsis-like illness with fever >38°C and a combination of irritability/pain, diarrhea, confluent erythematous rash, tachycardia, tachypnea, encephalitis, myoclonic jerks, and hepatitis. Inquiries revealed that neonates described as “red, hot, angry” had also been admitted to other tertiary children’s hospitals in NSW (6). An expert advisory group comprising staff from the NSW Ministry of Health, Health Protection NSW, public health units, and the Sydney Children’s Hospital Network was convened to coordinate the investigation.
On November 25, 2013, PCR detection of HPeV RNA confirmed HPeV infection in 2 of the children. The NSW public health network and clinicians agreed that a surveillance program should be initiated to gather information on the epidemiologic and clinical characteristics and outcomes of children with HPeV infection.
In addition to the public health response, Health Protection NSW issued a media release to alert members of the public to the outbreak. On November 29, 2013, HPeV3 information including a case definition, instructions for accessing diagnostic testing, and recommended clinical management was distributed to all emergency departments, pediatricians, and early childhood health services in NSW. During the outbreak, the expert advisory group met regularly via teleconference to discuss and address any emerging issues. HPeV3 active surveillance activities were concluded on January 31, 2014, while other forms of surveillance continued into February 2014. We describe the epidemiology of the outbreak as observed through several surveillance mechanisms.
Ms. Cumming is a public health specialist working with the NSW health system. Her research areas of interest include population health surveillance and evaluations and public health response preparedness.
We express our gratitude to clinicians at the sentinel sites and laboratory staff at South Eastern Areas Laboratory Services, Children’s Hospital Westmead Pathology, and Hunter Area Pathology Service. Particular thanks go to Stephanie Francis and Emma Goeman, Murray Webber, and Karin Timmers for their assistance with data collection and reporting to Public Health. We also thank the staff at the public health units for managing case information and laboratory results in the NSW Notifiable Conditions Information Management System, particularly Margaret Osbourn, Julie K. Kohlhagen, and Gareth Hockey. We thank the Ministry of Health staff, particularly Tracie Reinten, for statistical analysis contributions, and David Muscatello and Tina Navin-Cristina for continued weekly syndromic surveillance of HPeV infection in infants in NSW. We are very grateful for the knowledge, expertise, and advice received from our Expert Panel members, particularly Sheena Adamson, Stephen Corbett, David Durrheim, Alison Kesson, Tony Merritt, and Murray Webber. We appreciate the vital support received from VIDRL, particularly Julian Druce, for an excellent speedy turnaround of HPeV testing and genotyping, which was not available in NSW at the time.
This work was completed while G.C. was employed as a trainee in the NSW Public Health Officer Training Program funded by the NSW Ministry of Health.
- Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ. Human parechovirus 3 causing sepsis-like illness in children from Midwestern United States. Pediatr Infect Dis J. 2011;30:238–42.
- Sharp J, Harrison CJ, Puckett K, Selvaraju SB, Penaranda S, Nix WA, Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations. Pediatr Infect Dis J. 2013;32:213–6 .
- Fischer TK, Midgley S, Dalgaard C, Nielsen AY. Human parechovirus infection, Denmark. Emerg Infect Dis. 2014;20:83–7.
- Harvala H, Wolthers KC, Simmonds P. Parechovirus in children: understanding a new infection. Curr Opin Infect Dis. 2010;23:224–30.
- Guo Y, Duan Z, Qian Y. Changes in human parechovirus profiles in hospitalised children with acute gastroenteritis after a three-year interval in Lanzhou, China. PLoS ONE. 2013;8:e68321.
- Khatami A, McMullan B, Webber M, Stewart P, Francis S, Timmers K, Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia. Clin Infect Dis. 2015;60:228–36.
- Muscatello DJ, Churches T, Kaldor J, Zheng W, Chiu C, Correll P, An automated, broad-based, near real-time public health surveillance system using presentations to hospital emergency departments in New South Wales, Australia. BMC Public Health. 2005;5:141.
- Wolthers KC, Benschop KS, Schinkel J, Molenkamp R, Bergevoet RM, Spijkerman IJ, Human parechovirus as an important viral cause of sepsis-like illness and meningitis in young children. Clin Infect Dis. 2008;47:358–63.
- Shoji K, Komuro H, Miyata I, Miyairi I, Saitoh A. Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants. Pediatr Infect Dis J. 2013;32:233–6 .
- Druce J, Tran T, Kelly H, Kaye M, Chibo D, Kostecki R, Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002–2003. J Med Virol. 2005;75:122–9.
- Nix WA, Maher K, Pallansch MA, Oberste MS. Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing. J Clin Virol. 2010;48:202–7.
- Papadakis G, Chibo D, Druce J, Catton M, Birch C. Detection and genotyping of enteroviruses in cerebrospinal fluid in patients in Victoria, Australia, 2007–2013. J Med Virol. 2014;86:1609–13 .
- Australian Bureau of Statistics. Estimated resident population (ERP) by region, age, and sex, 2001 to 2013 [cited 2014 Feb 24].http://www.abs.gov.au/.
- Benschop KS, Schinkel J, Minnaar RP, Pajkrt D, Spanjerberg L, Kraakman HC, Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis. 2006;42:204–10.
- Lenski RE, May RM. The evolution of virulence in parasites and pathogens: reconciliation between two competing hypotheses. J Theor Biol.1994;169:253–65.
Suggested citation for this article: Cumming G, Khatami A, McMullan BJ, Musto J, Leung K, Nguyen O, et al. Parechovirus genotype 3 outbreak among infants, New South Wales, Australia, 2013–2014. Emerg Infect Dis. 2015 Jul [date cited]. http://dx.doi.org/10.3201/eid2107.141149
1Current affiliation: Independent consultant, Freshwater, New South Wales, Australia